1Banti S, Darigotti L, Abbracchio MP, et al. Methylazoxymethanol microencephaly in rats: neurochemical characteritation and behasioral studies with the nootropie oxiracetam[J]. Pharmacol Res Commun, 1984, 16(1): 67 - 83.
2Bottini G, Vallar G, Cappa S, et al. Oxiracetam in dementia: a doubleblina, placebor controlled study[J]. Arta Neurot Scand, 1992, 86(3): 237 - 241.
3Parnetti L, Mecocci P, Petrini A, et al. Neuropsychobiological results of long term therapy with oxiracetam in patients with dementia of Alzheimer type and muhr infarct dementia in comparison with a control group[J]. Neuropsychobiology, 1989, 22(2): 97 - 100.
4Casoy A. Van Golf-Racht B Delacout J Relationships between arousal and cognition-enhancing effects of oxiracetam[J] .Pharmacd Bilchen Bcher, 1994, 47(2): 283 - 287.
5RomanCC. Wascular domentia may be the most common from of domentia in the elderly. J Neurol sci, 2002,203 (4) :7 -10.
6Crorelick pB. status of rish factors for domentia associated with stroke, sroke , 1997,28 (2) : 15p463.
7Strub R. Vascular Dementia. South Med J, 2003,96 (4) : 363-366.
8American Psychiatric Association Diagnostic and statistical manul of mental disorders (DSM IV) [M]. 4 thed . Washington: Ameri can Psychiatric Assocation, 1994 : 143-147.
9Casoy A, Van Golf Racht B, Delacout J. Relationships between arousal and cognition enhancing effects of oxirhcethm[J]. Pharmacd Bilchen Beher, 1994,47(2) : 283-287.
